香港股市 已收市

STERIS plc (STE)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
203.90+2.36 (+1.17%)
收市:04:00PM EDT
204.71 +0.81 (+0.40%)
收市後: 07:37PM EDT

STERIS plc

70 Sir John Rogerson’s Quay
Dublin 2
Dublin D02 R296
Ireland
353 1 232 2000
https://www.steris.com

版塊Healthcare
行業Medical Devices
全職員工17,000

高階主管

名稱頭銜支付行使價出生年份
Mr. Daniel A. CarestioPresident, CEO & Director1.59M1973
Mr. Michael J. TokichSenior VP & CFO838.61k1969
Mr. John Adam ZangerleSenior VP, General Counsel & Secretary718.45k1.5M1967
Ms. Mary Clare FraserSVP & Chief Human Resources Officer555.75k1970
Mr. Cary L. MajorsSenior Vice President & President of Healthcare615.61k1975
Ms. Karen L. BurtonChief Accounting Officer, VP & Controller1968
Julie WinterVice President of Investor Relations & Corporate Communications
Ms. Julia K. MadsenSenior Vice President of Life Sciences1965
Mr. Andrew XilasSenior VP & GM of Dental1.44M1965
Kenneth E. KohlerSenior VP & GM of AST
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

公司管治

截至 2024年4月1日 止,STERIS plc 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:9;董事會:4;股東權利:8;現金賠償:5。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。